Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

BACKGROUND: Although dual-boosted protease inhibitors regimen is not recommended in children with HIV infection, such a strategy could be useful in subjects with a complex resistance profile. This study was aimed at assessing the long term efficacy and safety of a double-boosted protease inhibitor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rusconi, Stefano, Giacomet, Vania, Mameli, Chiara, Viganò, Alessandra, Viganò, Ottavia, Adorni, Fulvio, Galli, Massimo, Zuccotti, Gian Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434076/
https://www.ncbi.nlm.nih.gov/pubmed/22866946
http://dx.doi.org/10.1186/1471-2334-12-179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434076/
https://www.ncbi.nlm.nih.gov/pubmed/22866946
http://dx.doi.org/10.1186/1471-2334-12-179

Ejemplares similares